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ardy Pardee: Moving Medical
ffectiveness to the Forefront*
ames G. Jollis, MD, FACC
urham, North Carolina
inety years ago, the New York cardiologist Harold Ensign
ennett Pardee first gave rise to the entity of ST-segment
levation myocardial infarction (STEMI) in his description
f the electrocardiographic changes of acute coronary oc-
lusion as the takeoff of the T-wave from the descending
-wave (1). This ability to recognize acute coronary occlu-
ion became most important 20 years ago, when large
andomized trials demonstrated a survival benefit with the
imely administration of fibrinolytic therapy (2,3). The
elevance of these 2 discoveries goes far beyond historical
nterest, as we continue to be challenged in applying medical
iagnostics and therapeutics that are decades old. Registries
ndicate that roughly one-half of STEMI patients do not
ndergo electrocardiogram (ECG) or reperfusion in a
imely fashion and that 30% of eligible patients do not
eceive any reperfusion treatment at all. Classic system
See page 97
ailure scenarios include the patient with chest pain waiting
o register in a crowded emergency department, and delays
n primary angioplasty while the emergency physician at-
empts to identify which cardiology group “owns” the
atient and its preferred anticoagulant regimen. What has
een missing from medical science is the fundamental
ecognition that the greatest improvement in patient out-
omes will result from the establishment of systems to
outinely extend advances to every eligible patient. Efforts to
dvance medicine have traditionally concentrated on 3
hases: 1) basic science discovery, 2) translation to human
pplications, and 3) proof of efficacy in randomized clinical
rials. The enormous lag in our application of medical
iscoveries to all patients will only be reduced with sustained
fforts directed toward the fourth phase of medical thera-
eutics, systematic implementation. The difficulty of this
Editorials published in the JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
From Duke University, Durham, North Carolina. Dr. Jollis has received grantb
upport from Blue Cross Blue Shield of North Carolina, Genentech, and the Kate B.
eynolds Foundation.nal phase should not be underestimated, as success requires
he transformation of thousands of medical facilities and the
oordinated support of their associated personnel.
In this issue of JACC: Cardiovascular Interventions,
rumholz et al. (4) describe the methodology underlying a
ajor effort by the American College of Cardiology (ACC)
o fundamentally advance the treatment of STEMI through
ystematic improvement in the application of existing tech-
ologies. This intervention focused on improving coronary
eperfusion is likely to have health benefits on a similar scale
o clinical trials demonstrating improved survival, and the
etailed methodological description contained in this report
erves as a valuable model by which others may reach success
n this “final stage” of medical therapeutics.
Of the 2 fundamental steps in reperfusing acutely ob-
tructed coronary arteries, diagnosis and treatment, the
oor-to-Balloon (D2B) Alliance primarily focuses on the
atter step. Starting in January 2006, the D2B Alliance was
oined by 900 hospitals with a commitment to improve
oronary reperfusion according to the goal of “balloon
nflation” within 90 min of hospital arrival for 75% of
atients. Among numerous systems improvements required
o expedite care, the project selected 5 structural interven-
ions, including emergency medicine physician activation of
he catheterization laboratory with a single call, laboratory
vailability within 20 to 30 min, prompt feedback, forma-
ion of ST-segment elevation teams, and hospital adminis-
ration support. The intervention was further augmented by
number of tools, including the establishment of internet-
ased forums and the formation of a large alliance of health
are organizations and providers beyond cardiology.
Krumholz et al. (4) provide a detailed, step-by-step
escription of how one of the most effective professional
rganizations in cardiac care goes about transforming the
ealth system during a 2-year course to routinely provide
apid coronary reperfusion to every eligible patient. The
ork describes important components of the planning,
nrollment, intervention, and evaluation stages of the
roject, each focused on deriving maximal effectiveness. For
xample, in selecting recommended processes at hospitals
hat offer percutaneous coronary intervention (PCI), the
nitiative took a pragmatic stance and chose 5 recommen-
ations likely to be met with universal support. In this initial
hase, the alliance avoided recommendations likely to pose
ogistical or political obstacles, including attending cardiol-
gist always on-site, laboratory availability within 20 min,
nd laboratory activation by in-the-field electrocardiogra-
hy. The tools used to bolster enrollment included media
ttention surrounding the public announcement and the
ncouragement of hospital enrollment by state chapters and
ocal leaders. To make the intervention most effective, each
ospital was provided with customized recommendations
ased on enrollment surveys, and the effort was supported
y internet-based education.
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106The focus of the D2B Alliance on treatment rather than
iagnosis also reflects the wisdom of the group. Highly
ffective catheterization laboratory systems are a requisite to
pproaching emergency department and emergency medical
ervice personnel regarding rapid diagnosis. Once an
TEMI is diagnosed, primary angioplasty must be available
n a consistent and timely fashion. Even if hospitals and
hysicians chose to rely on fibrinolysis as the main approach
o coronary reperfusion, the subgroups of patients at risk for
leeding or who do not reperfuse with lysis, and those in
hock or older than 75 years of age must still have expedient
ccess to primary angioplasty. If emergency physicians and
edical technicians attempt to activate a cardiac catheter-
zation laboratory and that laboratory is not rapidly avail-
ble, any potential system for coronary reperfusion will
reak down, lacking credibility and support. Thus, it is
mperative that PCI hospitals implement the recommenda-
ions of the D2B Alliance as a requirement for participation
n local or regional ST-segment elevation reperfusion sys-
ems. The recommendation of “having the physician acti-
ate the catheterization laboratory with a single call” is of
articular importance. On the basis of the experience
rganizing a 65-hospital STEMI system, Jollis et al. (5)
ound that, to effectively implement single call activation,
atients must be immediately accepted for PCI regardless of
ed availability. The ideal center should have a single
nterventional cardiologist on call for all cases in which a
pecific cardiologist cannot be readily identified or available.
urthermore, physicians at the PCI hospital should reach a
onsensus regarding a common pre-procedure medical reg-
men, ideally one that is simple for emergency departments
o implement and transport crews to maintain.
Following the D2B Alliance, Krumholz et al. (4) note
hat the next target of this well organized and formidable
lliance involves an expansion to all hospitals. Currently,
pproximately 1,400 of 5,000 acute care hospitals in the
.S. perform PCI. To benefit the greatest number of
atients, reperfusion systems, particularly those involving
rimary angioplasty, need to be expanded to every hospital.
here are currently 2 approaches by national organizations
o achieving this goal. The ACC and others recommend
hat current guidelines set the standards, providing for
ither primary angioplasty or fibrinolysis after taking into
ccount available resources, myocardial infarction and
leeding risk, and time of onset and time to treatment. The
merican Heart Association has established “Mission Life-
ine,” a program designed to provide primary angioplasty to
ll patients whenever possible, categorizing hospitals as
ither “STEMI receiving” or “STEMI referring” according
o the availability of primary angioplasty. The pragmatic
esign of the former approach is most likely to be successful
ith existing healthcare resources. In the U.S., significant
arriers to a universal system of STEMI transfer exist,
ncluding deficiencies in emergency transport, hospital over- rrowding, reimbursement disincentives, and a lack of infor-
ation systems by which to track STEMI care and out-
omes between hospitals and EMS transport. According to
he most recent registry data, the median time of 3 h from
rst door to device for patients transferred between hospitals
or primary angioplasty indicates that many fundamental
mprovements like those supported by the D2B Alliance
eed to be implemented before primary angioplasty can be
onsidered the sole approach to coronary reperfusion. To
mprove transfer times, emergency department processes at
he STEMI-referring hospitals need to be streamlined.
uch improvements should include forgoing delays in copy-
ng charts and completing forms, giving Emergency Med-
cal Services (EMS) priority to patients requiring transfer
or PCI, and leaving patients likely to be transferred “on the
tretcher” of the initial EMS unit. An intervention that is
uideline recommended but operationally and politically
hallenging involves diversion of EMS patients from the
losest non-PCI hospital to a PCI-capable hospital, com-
letely avoiding delays of the first hospital (6).
Ten years before Pardee recognized ST-segment eleva-
ion, Willem Einthoven’s (7) initial electrocardiography
achine was termed “telecardiography,” as the tracings were
btained in the hospital and transmitted through special
elephone lines to a galvanometer 1 mile away in the
hysiology laboratory. The challenges of diagnosing acute
oronary occlusion today were foreshadowed in this early
xperience. “Upstream” diagnostic interventions have the
reatest potential to improve timely coronary reperfusion for
ll patients. Thus, the ACC and others are expanding their
cope to involve emergency medical technicians and emer-
ency department triage areas in rapid diagnosis. For the
MS, interventions should focus on providing adequate
edical dispatch and ECG equipment to respond to every
otential acute coronary scene, extending to basic and
ntermediate level emergency medical technicians the ability
o perform ECGs, and enabling paramedics to activate
eperfusion systems from the field. For the emergency
epartment, early diagnostic interventions should include
nurse first” evaluation of chest pain patients and the
rovision of dedicated space and protocols to perform and
nterpret ECGs in a timely fashion.
The final critical step in any medical intervention involves
easurement. Tracking patients, processes of care, and
utcomes allows for assessment of the intervention, and
ore importantly, data feedback to participants serves as a
trong impetus for change. The D2B Alliance will perform
hese measurements through a number of existing data
ources including follow-up hospital surveys, the ACTION
Acute Coronary Treatment and Intervention Outcomes
etwork) registry, and publicly reported hospital data from
he Center for Medicare and Medicaid Services (CMS) and
he Hospital Quality Alliance. Some significant gaps in data
emain to be closed. First, as systems move toward inter-
h
i
i
b
i
r
g
e
(
fi
r
d
t
t
t
p
f
“
s
A
r
n
g
n
t
t
m
t
c
w
p
o
p
N
t
d
i
d
o
R
D
C
R
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 1 , N O . 1 , 2 0 0 8
F E B R U A R Y 2 0 0 8 : 1 0 5 – 7
Jollis
Editorial Comment
107ospital transfer, an existing “blind spot” needs to be
lluminated. Patients who die in transfer are not reliably
dentified by any existing myocardial infarction registry. In
uilding STEMI transfer systems, such deaths must be
dentified to ensure transfer strategies in general practice
esults in the best outcomes. A particularly concerning
roup involves cardiogenic shock. Patients in shock were
xcluded from most randomized trials of STEMI transfer
8,9). However, the guidelines continue to favor PCI over
brinolysis for patients in shock, and thus systems that
outinely transfer shock patients should carefully track
eaths. A readily available method to identify deaths in
ransfer involves linking EMS data to hospital data, a step
hat would greatly enhance the ability of hospitals and EMS
o understand and improve care. Given concerns about
atient privacy, such a practical linkage may require support
rom federal or state statute.
Another significant data gap involves patients who are
transferred in” from another hospital for coronary reperfu-
ion, currently excluded from CMS and Hospital Quality
lliance data. More than one-half of patients treated at
egional PCI hospitals are transferred in, and given the
ational average of 3 h from first door to intervention, this
roup should be included in routine STEMI measures. The
ew requirement of CMS for reporting “median time to
ransfer for primary PCI” will substantially increase atten-
ion and measurement of these patients (10). Probably the
ost critical measurement issues involve the transition of
he National Registry of Myocardial Infarction (NRMI),
losed in 2006, to the ACTION registry. A national registry
ith broad participation and support from hospitals and
hysicians such as ACTION will provide the greatest
pportunity of assuring prompt coronary reperfusion for all
atients. In the conversion of NRMI to ACTION, key
RMI data elements germane to STEMI care from symp- 1om onset to reperfusion must be maintained and further
eveloped. With comprehensive data supporting major
nterventions like the D2B Alliance, T waves will promptly
escend from the R-wave to baseline and the full potential
f medical therapeutics will be made available to all patients.
eprint requests and correspondence: Dr. James G. Jollis,
uke University Medical Center, Box 3254, Durham, North
arolina 27710. E-mail: james.jollis@duke.edu.
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